WuXi is considering the sale of some US and European operations to mitigate the impact of upcoming restrictions.

Amidst the long-running Cas9 patent battle, Editas Medicine has struck a deal to sell a portion of its future revenue stream ...

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...

Two years after the FDA placed partial clinical hold, Avidity can resume research of del-desiran as a treatment for myotonic ...

It is common for sponsors to switch digital platforms between clinical trial phases, but sponsors can achieve much by using ...

Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults ...

Novo Nordisk’s chief scientific officer Marcus Schindler led the keynote address at ELRIG Drug Discovery 2024 in London, UK.

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Vevizye is used to treat moderate to severe DED in adults unresponsive to tear substitutes. Novaliq and Laboratoires Théa ...

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ...

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing ...